Boston Therapeutics, a developer of complex carbohydrate chemistry-based drugs that address diabetes, has signed a consulting agreement with Generosus Advisors, LLC and Fortified Management Group, LLC to market the SugarDown® dietary supplement in the United States on a non-exclusive basis.
SugarDown® is intended to support healthy blood sugar. In clinical studies the product demonstrated its capability to reduce after meal sugar spikes. Marketing efforts of SugarDown® will be conducted through the Help Now Network (HNN), a healthcare marketing company and its affiliates. Fulfillment of all customer orders for SugarDown® will also be managed by HNN, as well as other direct distribution channels.
HNN maintains a database through its affiliate of approximately 2 million members, many of whom fit the SugarDown® market demographic. SugarDown® will be test-marketed to this member-base via trained outbound call center outreach and electronic media.
"In our marketing agreement for SugarDown® in the United States, we are working with a company that has a broad knowledge of the needs of those who fit our ideal customer profile," Kenneth A. Tassey, Jr., president of Boston Therapeutics, stated in the news release. "HNN has created an impressive database of loyal members. We are confident that HNN will effectively communicate the benefits of SugarDown® to these individuals and efficiently distribute the product when orders are placed."
Thomas Scipione of HNN further explained the marketing company's experience with other products targeting diabetes management.
"We are very excited to introduce SugarDown® to our two million members. Over the past several years we have marketed many products that are beneficial to our members to help them better manage their disease. We plan to rollout a marketing campaign for SugarDown® in the next few weeks. Help Now Networks is in the business of lead generation through digital media and telemarketing services. For the past five years HNN's primary focus has been in healthcare of which diabetes has been our core campaign," said Scipione.
For more information visit bostonti.com
MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com